ロード中...
The chimeric transcript RUNX1–GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer
Stage IA non-small-cell lung cancer cases have been recognized as having a low risk of relapse; however, occasionally, relapse may occur. To predict clinical outcome in Stage IA non-small-cell lung cancer patients, we searched for chimeric transcripts that can be used as biomarkers and identified a...
保存先:
| 出版年: | Jpn J Clin Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4731000/ https://ncbi.nlm.nih.gov/pubmed/26685324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyv187 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|